首页 | 本学科首页   官方微博 | 高级检索  
     

原发性中晚期肝癌19例三维适形放疗疗效分析
引用本文:张智策,许建林,朱姣,卢佳. 原发性中晚期肝癌19例三维适形放疗疗效分析[J]. 现代肿瘤医学, 2007, 15(10): 1472-1473
作者姓名:张智策  许建林  朱姣  卢佳
作者单位:陕西省肿瘤医院,陕西,西安,710061
摘    要:目的:观察三维适形放射治疗对中晚期原发性肝癌的疗效。方法:回顾分析19例中晚期原发性肝癌行三维适形放射治疗效果,TD38Gy~48Gy/7~12次/2.5~3周。同期30例肝动脉介入 碘油栓塞作为对照。结果:对照组近期疗效有效率70.0%(21/30),观察组78.9%(15/19);对照组与观察组1,2,3年生存率分别为53.3%、26.7%、13.3%,73.7%、42.2%、21.1%。结论:三维适形放射治疗对中晚期原发性肝癌,疗效不亚于动脉介入 碘油栓塞,值得临床推广。

关 键 词:中晚期原发性肝癌  三维适形放射治疗(3-DCRT)  肝动脉介入治疗
文章编号:1672-4992-(2007)10-1472-02
修稿时间:2006-12-28

Three dimensional conformal radiaotherapy for 19 cases of primary liver cancer
ZHANG Zhi-ce,XU Jian-lin,ZHU Jiao,LU Jia. Three dimensional conformal radiaotherapy for 19 cases of primary liver cancer[J]. Journal of Modern Oncology, 2007, 15(10): 1472-1473
Authors:ZHANG Zhi-ce  XU Jian-lin  ZHU Jiao  LU Jia
Abstract:Objective:To observe the effect of three dimensional conformal radiaotherapy(3-DCRT) for middle and late stage primary liver cancer.Methods:Total of 19 cases(group A) were treated by 3-DCRT,DT:38~48Gy/7~12f/2.5~3W,30 cases treated by transcatheter arterial chemobolization(TACE) were control(group B).Results:The near effective rate in group B was 70%(21/30),in group A 78.9%(15/19);The 1,2,3 year survival rates in group B and group A were 53.3%,26.7%,13.3%;73.7%,42.2%,21.1%.Conclusion:3-DCRT for the middle and late stage primary liver cancer is effective.
Keywords:middle and late stage primary liver cancer  3-DCRT  TACE
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号